Scientific Sessions

Scientific Sessions

10:00 - 10:15

OPENING SESSION

Chair: Dr Yuval (Tuby) Zolotov, Ben Gurion University of the Negev, Israel

Dr Staci Gruber, McLean Hospital; Harvard Medical School, USA

Moderator: Prof. Mike Barnes, The Medical Cannabis Clinicians Society (MCCS), UK

Prof. Raphael Mechoulam, The Hebrew University of Jerusalem, Israel

12:00 - 13:20

.

12:00 – 13:15
MEDICAL CANNABIS AND CANNABIONIDS IN NEUROLOGICAL CONDITIONS

Chair: Prof. Mike Barnes, The Medical Cannabis Clinicians Society (MCCS), UK

12:00 – 12:15
MEDICAL CANNABIS AND CANNABINOIDS IN CHILDREN WITH AUTISM
Dr. Adi Aran, Neuropediatric Unit, Shaare Zedek Medical Center, Israel,

12:15 – 12:30
MULTIPLE SCLEROSIS AND OTHER NEUROLOGICAL CONDITIONS
Prof. Mike Barnes, The Medical Cannabis Clinicians Society (MCCS), UK

12:30 – 12:45
MOVEMENT DISORDERS 
Dr. Simon Levy, Sheba Hospital, Israel

12:45 – 13:00
CANNABIS IN MIGRAINE 
Dr. Laszlo MechtlerDENT Neurologic InstituteUSA

13:00 – 13:15
Q&A

12:00 – 13:15
INNOVATIVE TECHNOLOGIES FOR THE MEDICALL CANNABIS SUPPLY CHAIN

Industry session not included in the main event CME/CPD credit

Click HERE for the session content

 

.

14:30 – 15:00
ORIGINAL STUDIES: RAPID PRESENTATIONS
PART I

Each slot includes 5 min for presentation + 2 min Q&A

Chair: Dr. Rosemary Duda, Beth Israel Deaconess Medical Center; Harvard Medical School, USA

14:30 – 14:32
Introduction

14:32 – 14:39
METABOLIC EFFECTS OF MEDICAL CANNABIS TREATMENT
Dr. George Habib
Laniado Hospital, Netanya and Nazareth Hospital, Israel

14:39 – 14:46
ADDRESSING THE OPIOID EPIDEMIC WITH RESEARCH AND REAL-WORLD DATA-INFORMED APPROACHES 
Dr. Marion McNabb, Cannabis Center of Excellence, USA

14:46 – 14:53
MEDICAL CANNABIS SIGNIFICANTLY DECREASES AVERAGE PAIN SCORE FOLLOWING ONLY THREE MONTHS OF USE 
Dr. Rosemary Duda, Beth Israel Deaconess Medical Center; Harvard Medical SchoolUSA

14:53 – 15:00
VAPORISED MEDICAL GRADE CANNABINOIDS AS RESCUE MEDICATION IN ACUTE ANXIETY – A VALIDATION AUDIT OF ADULTS PATIENTS IN AN URGENT CARE DEPARTMENT 
Dr. Gabor Xantus, University of Pécs, Hungary

15:00 – 15:30
ORIGINAL STUDIES: RAPID PRESENTATIONS PART II

Session not included in the main CME/CPD credit

Click HERE for the session content

14:30 – 15:30
SESSIONEMERGING EUROPEAN MARKETS 

Industry session not included in the main event CME/CPD credit

Click HERE for the session content

Chair: Dr. Jeffrey Hergenrather, Society of Cannabis Clinicians, USA

16:00 - 16:20
CANNABIS IN INTEGRATIVE MEDICINE
Dr. Jeffrey Hergenrather, Society of Cannabis Clinicians, USA

16:20 - 16:40
MEDICAL CANNABIS FOR OLDER ADULTS
Dr. Mikhail Kogan, GW Center for Integrative Medicine, USA

16:40 - 17:00
CANNABINOID HYPEREMESIS SYNDROME
Dr. Ethan Russo, Member, Cannabis Expert Panel, USA

17:00 - 17:20
EVALUATING PATIENTS AND MONITORING LONG-TERM TREATMENTS WITH CANNABIS AND CANNABINOIDS
Dr. Alan Shackelford, Member, Cannabinoid Research Initiative of Saskatchewan, University of Saskatchewan, USA

17:20 - 17:30
Q&A

17:30 - 18:30

WELCOME RECEPTION

.

.

09:30 - 10:30

.

09:30 – 10:30
PANEL DISCUSSION: MEDICAL CANNABIS COMPETENCIES: RATIONALE AND INITIAL DEVELOPMENT OF EVIDENCE-BASED CURRICULUM FOR HEALTHCARE PROFESSIONALS

Session in partnership with RADAR Center at Ben Gurion University of the Negev

Moderator: Dr. Yuval (Tuby) Zolotov, Ben Gurion University of the Negev, Israel

Panelists:

  • Dr. Mikhail Kogan, GW Center for Integrative Medicine, USA
  • Dr. Leslie Mendoze Temple, NorthShore University HealthSystem, USA
  • Dr. Yuval (Tuby) Zolotov, Ben Gurion University of the Negev, Israel
  • Prof. Richard Isralowitz, Ben Gurion University of the Negev, Israel 

09:30 – 10:30
SPONSORS

Industry session not included in the main event CME/CPD credit

Click HERE for the session content

11:00 - 12:00

.

11:00 – 12:00
PRECLINICAL SESSION IN MEMORY OF PROF. ITAY BAB

Chair: Yossi Tam, The Hebrew University of Jerusalem, Israel

11:00 – 11:12
ACTIVATION OF CB2 RECEPTOR MEDIATES NEUROPROTECTION AFTER TRAUMATIC BRAIN INJURY
Prof. Esther Shohami, Faculty of Medicine, The Hebrew University of Jerusalem, Israel

11:12 – 11:24
THE ANTI-TUMORIGENIC ROLE OF CANNABINOID RECEPTOR 2 IN COLON CANCER
Prof. Yankel Gabet, Tel Aviv University of the Negev, Israel

11:24 – 11:36
PHYTOCANNABINOIDS FOR TREATING NON-ALCOHOLIC FATTY LIVER DISEASE, DYSLIPIDEMIA, AND TYPE 2 DIABETES
Prof. Yossi Tam, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Israel

11:36 – 11:48
THE CHALLENGE OF DEVELOPING SELECTIVE DRUGS TOWARDS THE COMPLEX ENDOCANNABINOID SYSTEM
Prof. Mauro Maccarone, University of L’Aquila, Italy

11:48 – 12:00
Q&A

11:00 – 12:00
SESSION

Industry session not included in the main event CME/CPD credit

Click HERE for the session content

Chair: Dr. Yuval Zolotov, Ben Gurion University of the Negev, Israel

Prof. David (Dedi) Meiri, Technion Israel Institute of Technology, Israel

13:45 - 14:45

.

13:45 – 14:45
ORAL PRESENTATIONSSCIENCE

NOVEL CANNABIDIOL (CBD)-INFUSED ABSORBABLE IMPLANT DELIVERY SYSTEM FOR NEUROTRAUMA 
Dr. Linda FriedmanNew York Medical CollegeUSA

THE CHEMOTYPES I AND III OF CANNABIS SATIVA L INDUCE DISTINCT TYPES OF CELL DEATH (APOPTOSIS / NECROSIS) IN HUMAN LEUKEMIC CELL LINES 
Prof. Sandra Santander GonzalezUniversity Foundation Juan N Corpas, Colombia

CANNABINOIDS AND CANNABIS EXTRACTS AFFECT METABOLIC SYNDROME PARAMETERS INCLUDING MICROBIOME IN MICE FED HIGH FAT-CHOLESTEROL DIET 
Dr. Jonathan Gorelick, Eastern R&D Center, Israel

POSSIBLE MODULATION OF THE NEURO-ENDOCRINE-CYTOKINE NETWORK BY   THE PINEAL HORMONE MELATONIN AND CANNABIDIOL IN PSYCHOLOGY 
Prof. Giusy Messina, International Institute of Pnei, Italy

CANNABIDIOL DOWNREGULATES THE EXPRESSION OF THE HUMAN FAM111B GENE IN LUNG ADENOCARCINOMA 
Dr. Afolake ArowoloUniversity of Cape Town, South Africa

HARNESSING CANNABIS MOLECULES TO FIGHT INFLAMMATION-ASSOCIATED DEPRESSION 
Prof. Raz Yirmiya, The Hebrew University of Jerusalem Israel

13:45 – 14:45
ORAL PRESENTATIONS: BUSINESS/ AGRICULTURE

Industry session not included in the main event CME/CPD credit

Click HERE for the session content

14:45 - 15:45

.

14:45 – 15:45
CANNABIS AND CANNABINOIDS FOR SPECIFIC CLINICAL CONDITIONS PART I

Chair: TBC

14:45 – 15:00
TBC 

15:00 – 15:15
CANNABIS AND CHRONIC PAIN: THE LONG STRANGE TRIP CONTINUES
Dr. Kevin Boehnke, University of Michigan Medical School, USA

15:15 – 15:30
TBC

15:30 – 15:45
Q&A

14:45 – 15:45
TBC

Industry session not included in the main event CME/CPD credit

Click HERE for the session content

16:15 - 17:15

.

16:15 – 17:15
CANNABIS AND CANNABINOIDS FOR SPECIFIC CLINICAL CONDITIONS PART II

Each slot includes 10 min for presentation + 5 min Q&A

Chair: Prof. Howard Amital, Sheba Medical Center, Israel

16:15 – 16:30
CANNABIS AND OPIOIDS FOR PAIN MANAGEMENT

Dr. Leora Schachter, Meuhedet Health Care Organization, Israel

16:30 – 16:45
FIBROMYALGIA & OTHER RHEUMATOLOGY CONDITIONS
Prof. Howard Amital, Sheba Medical Center, Israel

16:45 – 17:00
CARDIOVASCULAR AND METABOLIC IMPLICATIONS OF CANNABIS IN OLDER ADULTS 
Dr. Ran Abuhasira, Rabin Medical Center, Israel  

17:00 – 17:15
MEDICAL CANNABIS FOR PSYCHIATRIC CONDITIONS: CURRENT STATUS IN ISRAEL 
Dr. Ilya Reznik, MaReNa Diagnostic and Consulting Center, Israel

16:15 – 17:15
SESSION PANEL DISCUSSION

Industry session not included in the main event CME/CPD credit

Click HERE for the session content

Chair: Dr. Nirit Bernstein, Volcani Center, Israel

17:30 - 17:50
SCIENCE-BASED CULTIVATION TECHNOLOGIES FOR CANNABIS PRODUCTION
Dr. Nirit Bernstein, Volcani Center, Israel

17:50 - 18:10
DEVELOPING A REAL-WORLD EVIDENCE BASE FOR PRESCRIBED CANNABIS IN THE UNITED KINGDOM: FINDINGS FROM PROJECT TWENTY21
Dr. Anne Katrin Schlag, Head of Research, Drug Science; Imperial College London, UK

18:10 - 18:30
CANNABIS SAFETY UPDATES: IMPAIRMENT, OPIOIDS & PATIENT COMPLEXITIES
Dr. Caroline MacCallum, Faculty of Medicine, University of British Columbia, Canada

18:30 - 18:45
Q&A

18:30 - 18:45

CLOSING REMARKS

* could be subject to change